Warning: Missing argument 1 for get_pagelink_by_slug(), called in /export/sd09/www/jp/r/e/gmoserver/7/3/sd0131973/jpcnma.or.jp/wp-content/themes/jpcnma/header.php on line 111 and defined in /export/sd09/www/jp/r/e/gmoserver/7/3/sd0131973/jpcnma.or.jp/wp-content/themes/jpcnma/admin/functions-theme-basic.php on line 98

期刊《日中医学》

特辑:中日两国消化道癌症治疗的最前线

前言 日中两国消化道癌症治疗的最前线

杏林大学医学系附属医院消化道、普外科 教授
正木忠彦

中国结直肠癌治疗的最前线

浙江大学医学院附属第一医院消化内科
虞朝辉※1、马 丹
※1.主任

Advances in clinical treatment of colorectal cancer
 

【Abstract】
Colorectal cancer is one of the most common digestive tract tumors, and its morbidity and mortality have been rising dramatically in recent years. At present, the main treatment methods for colorectal cancer include surgery, radiotherapy and chemotherapy, targeted therapy, immunotherapy, and traditional Chinese medicine. In particular, targeted drugs and immunotherapy drugs have achieved good results in clinical treatment, which can significantly improve the prognosis, prolong the survival period, and improve the quality of life of patients.

【Key words】
Colorectal cancer, Clinical treatment, Advances

中国肝胆胰恶性肿瘤治疗的最前线

杭州医学院临床学院
浙江省人民医院浙江省肿瘤分子诊断与个体化治疗研究重点实验室
(杭州医学院附属人民医院)
黄东胜※1、梁 磊、杨 田
※1.教授(通讯作者)

浙江省人民医院肝胆胰外科·微创外科
(杭州医学院附属人民医院)
梁 磊、杨 田、张成武

The progress of treatments for hepatobiliary and pancreatic cancers in China
 

【Abstract】
Primary hepatobiliary and pancreatic tumors are common clinical malignancies, with an increasing incidence and poor prognosis. In order to improve the clinical diagnosis, treatment and research level of hepatobiliary and pancreatic tumors, promote related translational and clinical research, and strengthen academic exchanges and scientific and technological cooperation, we hereby describe the progress of the treatment for hepatobiliary and pancreatic cancer in China.

【Key words】
hepatocellular carcinoma, biliary tract cancer, pancreatic cancer, treatment, prognosis

日本结直肠癌治疗的最前线

日本红十字会医疗中心大肠肛门外科
佐佐木慎※1、赤井隆司、金子 学、丰岛 明※2
※1.部长 ※2.副部长

Forefront of colorectal cancer treatment in Japan
 

【Abstract】
Although JCOG0404 couldn’t confirm non-inferiority of laparoscopic surgery for colon cancer to open, it could be interpreted it is acceptable. Minimally invasive surgery including laparoscopic, robot-assisted, and TaTME will probably continue to increase. Furthermore, the treatment outcome for rectal cancer will improve by setting of appropriate adaptation criteria of lateral lymph node dissection and preoperative chemoradiotherapy, and by evaluation of blood flow at the anastomotic site using ICG fluorescence imaging.

【Key words】
laparoscopic colorectal surgery, robotic-assisted laparoscopic surgery, preoperative chemoradiotherapy, lateral lymph node dissection, indocyanine green fluorescence imaging

日本肝癌与胰腺癌治疗的最前线

杏林大学医学部付属医院肝胆胰腺外科
阪本良弘※1、百濑博一、松木亮太、小暮正晴、铃木 裕、森 俊幸
※1.诊疗科长、教授

The front lines of the treatments for liver and pancreatic cancer in Japan
 

【Abstract】
In the recent 20 years, survival rate of patients with unresectable hepatocellular carcinoma has improved owing to the development of owing to the development of chemotherapy using molecular targeted drugs and immune checkpoint inhibitor. Multidisciplinary treatment for resectable/borderline resectable/unresectable pancreatic cancer has also progressed owing to the combination of aggressive surgical resection and advance of systemic chemotherapy.

【Key words】
Hepatocellular carcinoma, molecular targeted drug, immune checkpoint inhibitor, pancreatic cancer, adjuvant chemotherapy

 

纽 带 
      
      

有幸在“第七届世界中西医结合大会” 上演讲
近藤诊所 院长
近藤高志

访 谈
采访在日中国学者

利用干细胞的多功能性,阐明各种疾病的病理状态、研发有效疗法
长崎大学核爆后障碍医疗研究所 干细胞生物学领域 教授
李桃生

笹川生 in China 
     
     

笹川医学奖学金开启了我人生的另一道门
上海市東方病院(同済大学附属東方病院)胃腸外科 主治医師
张 顺

后 记 宣传委员会委员  须并英二
期刊《日中医学》一般投稿征稿通知